How effective is Timoptic for Closed Angle Glaucoma (Glaucoma)? (a real world drug study)

Summary:

Overall ratings: 3.6/5
Long term ratings: 3.8/5

This is a phase IV clinical study of how effective Timoptic (timolol maleate) is for Closed angle glaucoma and for what kind of people. The study is created by eHealthMe from 20 Timoptic users and is updated continuously.

What is Timoptic?

Timoptic has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 4,247 Timoptic users. Check the latest studies of Timoptic.

What is Closed angle glaucoma?

Closed angle glaucoma (pressure inside your eye rises quickly) is found to be associated with 1,890 drugs and 1,685 conditions by eHealthMe. Check the latest studies of Closed angle glaucoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 22, 2026

20 people are studied for taking Timoptic in Closed angle glaucoma

Overall effectiveness (number of people):

Does Timoptic work for your Closed angle glaucoma (overall)?

Long term (1+ years) effectiveness (number of people):

Does Timoptic work for your Closed angle glaucoma (long term)?

Timoptic effectiveness for Closed angle glaucoma (number of people):

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 7
  • high: 7
  • very high: 4
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 5
  • high: 7
  • very high: 4

Gender of people who take Timoptic for Closed angle glaucoma *:

  • female: 65 %
  • male: 35 %

Age of people who take Timoptic for Closed angle glaucoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10 %
  • 50-59: 15 %
  • 60+: 75 %

Who find Timoptic more effective for Closed Angle Glaucoma?

Gender of people who take Timoptic for Closed angle glaucoma *:

  • female: 54.55 %
  • male: 45.45 %

Age of people who take Timoptic for Closed angle glaucoma *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.09 %
  • 60+: 90.91 %

* Approximation only. Some reports may have incomplete information.

Do you take Timoptic?

- You can start a phase IV clinical trial to monitor Timoptic safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on timolol maleate (the active ingredients of Timoptic) and Timoptic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: